Search

BCN HEALTH has published 11 studies in 2021 assessing the incidence and cost of illness of different diseases in Spain

The biopharmaceutical company, based at the BIC Bizkaia bioincubator, is also supplying its investigational biological drug MBK-01 under compassionate use

The upcoming edition of this event will be held on 28 April in Madrid, with over 300 participants and 50 investors from all over Europe

For World Health Day, we spoke with our members about the transversal nature of biotechnology and how work from one area can be applied in others, boosting animal, human and planet health

Peaches Biotech publishes in Biomolecules its work on how the immune system communicates with tissues that have been damaged or attacked by viruses or bacteria The Peaches Biotech drug belongs to a

Safety reporting is a crucial aspect of a successful clinical investigation for medical devices. Which are required to comply with the Medical Devices Regulation (EU) 2017/745 (MDR) and follow the

The Barcelona Science Park (PCB), in 2021 and the first two months of 2022, attracted 25 companies, consolidating its place among the most important hubs in Europe in the life sciences and healthcare

The incorporation comes in as the company launches important trials in the area of immunological oncology and regenerative tissue immunology.

The study will evaluate the safety and efficacy of ApTOLL in 30 patients with COVID-19 at four Spanish hospitals

Los fármacos donados desde 2007 han llegado a más de 600 millones niños de África subsahariana

In 2019 Immunostep R&D team recognized the great potential of these small extracellular vesicles and since then they have been working on the development of a line of products for research

The funds will be used to fuel pre-clinical trials for 5 different types of cancer

It is a recognition granted by Másfamilia Foundation that recognizes those entities that, from their structure and organization, contribute most to work and family life balance

The objective of this study was to evaluate the incidence of the disease at the hospital level and to calculate the associated medical costs

The biotechnology firm completes the seed round funding with a total of €6 million led last December by AdBio Partners, Invivo Capital and Takeda Ventures The Integra Therapeutics gene writing

On 28 April, AseBio Investor Day will bring together more than 50 investors from all over the world with disruptive biotech companies so they can meet and consolidate connections. We spoke with some

Extensive academic and industry experience in hematology/oncology Will coordinate Oryzon’s global clinical development from Boston, USA